SITC 2015 Annual Meeting & Associated Programs: Global Regulatory SummitNovember 4, 2015Gaylord National Hotel & Convention Center National Harbor, MDProgram Organizers
Ke Liu, MD, PhD – U.S. Food and Drug AdministrationPatrick Celis, PhD – European Medicines AgencyProgram Summary
The Global Regulatory Summit provided attendees with key information from regulatory agencies in cancer immunotherapy product development from various regions of the world and promoted scientific exchange between academia, government regulatory bodies and industry. The attendees of this program learned about and participated in the discussion on a variety of specific regulatory considerations and requirements, including pre-clinical and clinical trial issues, for immunotherapy products. Speakers focused their presentations on their country's regulatory perspectives and requirements as well as addressed audience questions. A panel discussion concluding the program addressed questions posed by both faculty members and the audience members in attendance.Intended Audience
This interactive symposium assembled thought-leaders from around the world in the field to discuss regulatory barriers on a global level. The target audience for this program included clinicians, industry representatives, government representatives, translational and basic scientists, graduate students, post-doctoral fellows, as well as other allied health professionals who are involved in clinical trials in the area of immunotherapy product development.
This library resource entry requires a SITC CONNECT account. Click the Sign In button at the top of this page, otherwise click here to create a FREE SITC CONNECT.
With a free SITC CONNET account, you can begin accessing hundreds of cancer immunotherapy resources in the SITC CONNECT Archive and Resource Libraries. Once your account is created, return to this page, refresh, and a download link should appear.
The SITC connectED education portal is supported by independent educational grants from AstraZeneca Pharmaceuticals LP and Merck & Co., Inc.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org